Literature DB >> 28543817

Influence of diabetes mellitus on immunity to human tuberculosis.

Pavan Kumar Nathella1,2, Subash Babu1,3.   

Abstract

Type 2 diabetes mellitus(DM) is a major risk factor for the development of active pulmonary tuberculosis (TB), with development of DM pandemic in countries where TB is also endemic. Understanding the impact of DM on TB and the determinants of co-morbidity is essential in responding to this growing public health problem with improved therapeutic approaches. Despite the clinical and public health significance posed by the dual burden of TB and DM, little is known about the immunological and biochemical mechanisms of susceptibility. One possible mechanism is that an impaired immune response in patients with DM facilitates either primary infection with Mycobacterium tuberculosis or reactivation of latent TB. Diabetes is associated with immune dysfunction and alterations in the components of the immune system, including altered levels of specific cytokines and chemokines. Some effects of DM on adaptive immunity that are potentially relevant to TB defence have been identified in humans. In this review, we summarize current findings regarding the alterations in the innate and adaptive immune responses and immunological mechanisms of susceptibility of patients with DM to M. tuberculosis infection and disease.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; T cells; diabetes mellitus; latent tuberculosis; monocytes and dendritic cells; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28543817      PMCID: PMC5543489          DOI: 10.1111/imm.12762

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  92 in total

1.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  Mechanisms of granule-dependent killing.

Authors:  S P Cullen; S J Martin
Journal:  Cell Death Differ       Date:  2007-11-02       Impact factor: 15.828

3.  Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection.

Authors:  Nathella Pavan Kumar; Parakkal Jovvian George; Paul Kumaran; Chandra Kumar Dolla; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

4.  The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study.

Authors:  Meghan A Baker; Hsien-Ho Lin; Hsing-Yi Chang; Megan B Murray
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

5.  Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis.

Authors:  C H Wang; C T Yu; H C Lin; C Y Liu; H P Kuo
Journal:  Tuber Lung Dis       Date:  1999

Review 6.  Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.

Authors:  Ben J Marais; Knut Lönnroth; Stephen D Lawn; Giovanni Battista Migliori; Peter Mwaba; Philippe Glaziou; Matthew Bates; Ruth Colagiuri; Lynn Zijenah; Soumya Swaminathan; Ziad A Memish; Michel Pletschette; Michael Hoelscher; Ibrahim Abubakar; Rumina Hasan; Afia Zafar; Guiseppe Pantaleo; Gill Craig; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

7.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

8.  Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection.

Authors:  Bisweswar Nandi; Samuel M Behar
Journal:  J Exp Med       Date:  2011-10-03       Impact factor: 14.307

Review 9.  The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world.

Authors:  Timothy Sullivan; Yanis Ben Amor
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  53 in total

1.  Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses.

Authors:  Matthew J Magee; Susanna L Trost; Argita D Salindri; Genet Amere; Cheryl L Day; Neel R Gandhi
Journal:  Tuberculosis (Edinb)       Date:  2020-04-02       Impact factor: 3.131

2.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

3.  Enhanced Mycobacterial Antigen-Induced Pro-Inflammatory Cytokine Production in Lymph Node Tuberculosis.

Authors:  Gokul Raj Kathamuthu; Kadar Moideen; Rathinam Sridhar; Dhanaraj Baskaran; Subash Babu
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

4.  Diabetes Mellitus and Tuberculosis Comorbidity and Associated Factors Among Bale Zone Health Institutions, Southeast Ethiopia.

Authors:  Habtamu Gezahegn; Mohammed Ibrahim; Elias Mulat
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-21       Impact factor: 3.168

5.  A Paradigm Gap in Host-Pathogen Interaction Studies: Lesson from the COVID-19 Pandemic.

Authors:  Murugesan Pooranachithra; Balasubramanian Chellammal Muthubharathi; Krishnaswamy Balamurugan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection.

Authors:  Peng Cheng; Liang Wang; Wenping Gong
Journal:  Front Microbiol       Date:  2022-06-28       Impact factor: 6.064

7.  Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis.

Authors:  Meng Zhang; Jian-Qing He
Journal:  Eur J Clin Pharmacol       Date:  2019-11-30       Impact factor: 2.953

8.  Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus.

Authors:  Miriam Bobadilla-Del-Valle; Francisco Leal-Vega; Pedro Torres-Gonzalez; Anabel Ordaz-Vazquez; Maria de Lourdes Garcia-Garcia; Ma de Los Angeles Tovar-Vargas; Guadalupe Delgado-Sanchez; Paola Del Carmen Guerra De Blas; Robert S Wallis; Alfredo Ponce-De-León; José Sifuentes-Osornio
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

9.  Anemia, sarcopenia, physical activity, and the risk of tuberculosis in the older population: a nationwide cohort study.

Authors:  Jung Eun Yoo; Dahye Kim; Hayoung Choi; Young Ae Kang; Kyungdo Han; Hyun Lee; Dong Wook Shin
Journal:  Ther Adv Chronic Dis       Date:  2021-05-31       Impact factor: 5.091

Review 10.  Modulating the foreign body response of implants for diabetes treatment.

Authors:  Bhushan N Kharbikar; Gauree S Chendke; Tejal A Desai
Journal:  Adv Drug Deliv Rev       Date:  2021-01-21       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.